Insomnia is underdiagnosed and undertreated in older patients. Self-treatment with alcohol or over-the-counter products containing first-generation antihistamines is common, resulting in suboptimal sleep patterns. For these patients, identifying sleep hygiene issues can raise awareness of sleep patterns that need to be changed. Cognitive behavioral therapy has proven efficacy as first-line treatment for insomnia. Not all patients, however, respond to nonpharmacologic treatment alone; therefore, supplementing nonpharmacologic treatment with a pharmacologic agent may be indicated. The risks of the pharmacologic agent need to be balanced with its benefits, and the patient’s sleep pattern and age should be taken into account when selecting the optimal dose. In this activity, three experts in sleep disorders and primary care discuss current strategies and therapies for managing insomnia in older patients.
Interactive eNewsletter in printable format
After completing this activity, the participant should be better able to:
- Review nonpharmacologic treatments for insomnia in older patients
- Demonstrate familiarity with the mechanisms of action of pharmacologic agents used to treat insomnia in older patients
- Appraise clinical evidence supporting the safety and efficacy of pharmacologic agents used to treat insomnia according to sleep patterns in older patients
- Use the optimal dose of pharmacologic agents to treat insomnia in older adult patients
This activity is intended for primary care physicians, NPs, and PAs engaged in the care of patients with insomnia.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedEdicus LLC. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 1.0 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
AAPA Credit Designation Statement
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until December 31, 2019. PAs should only claim credit commensurate with the extent of their participation.
This activity is supported by an educational grant from Merck & Co., Inc.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Stephen Brunton, MD, has nothing to disclose.
Thomas Roth, PhD: consulting fees: Avadel; Eisai Inc; Idorsia Pharmaceuticals Ltd; Jazz Pharmaceuticals Inc; Merck & Co., Inc; Novartis Pharmaceuticals Corporation; and SEQ.
Wendy Wright, NP: consulting fees: Arbor Pharmaceuticals; Merck & Co., Inc; Pfizer Inc; and Sanofi; Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (eg, speakers’ bureaus): Merck & Co., Inc; Pfizer Inc; and Sanofi.
Planners and Managers
The PIM planners and managers have nothing to disclose. The MedEdicus planners and managers have nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants wishing to earn CE/CME credit must:
- Read the eNewsletter in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 75%.
The estimated time to complete this activity is 1.00 hour.
Release date: December 31, 2018
Expiration date: December 31, 2019
This CE/CME activity is copyrighted to MedEdicus LLC © 2019. All rights reserved. 172
Internet Explorer 8.0+ for Windows 2000, 2003, XP, Vista, or Windows 7, 8, or 10
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5+
© 2019 Practicing Clinicians Exchange. All Rights Reserved. MPCE94318